Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina I Deligianni

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultationDimos D Mitsikostas, Christina I Deligianni
Journal of Medical Economics|March 1, 2024
Placebo responses vary by route of administration in migraine prevention trials. What does this mean?Christina I Deligianni, Paolo Martelletti, Dimos D Mitsikostas
Expert Opinion on Drug Safety|May 26, 2021
Safety and tolerability evaluation of erenumab for the preventive treatment of migraineChristina I Deligianni, Dimos D Mitsikostas, Messoud Ashina
The Journal of Headache and Pain|March 31, 2017
Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcomeDimos D Mitsikostas, Srdjan Ljubisavljevic, Christina I Deligianni
Current Opinion in Neurology|May 2, 2012
Depression in headaches: chronificationChristina I Deligianni, Michail Vikelis, Dimos D Mitsikostas
The Journal of Headache and Pain|September 3, 2015
Neck pain in episodic migraine: premonitory symptom or part of the attack?Christian Lampl, Mirjam Rudolph, Christina I Deligianni, et al.
Cephalalgia : an International Journal of Headache|February 11, 2021
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysisKonstantina Drellia, Lili Kokoti, Christina I Deligianni, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far?Theodoros Mavridis, Christina I Deligianni, Georgios Karagiorgis, et al.
Pain Management|May 30, 2025
Repurposed versus disease-specific medicinals for the prophylaxis of migraine: an updated systematic reviewSavvas-Ilias Christofilos, Theodoros Mavridis, Viktor Gkotzamanis, et al.
Cephalalgia : an International Journal of Headache|August 10, 2022
Visual snow: A systematic review and a case seriesStefanos N Sampatakakis, Loukas Lymperopoulos, Theodoros Mavridis, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultationDimos D Mitsikostas, Christina I Deligianni
Journal of Medical Economics|March 1, 2024
Placebo responses vary by route of administration in migraine prevention trials. What does this mean?Christina I Deligianni, Paolo Martelletti, Dimos D Mitsikostas
Expert Opinion on Drug Safety|May 26, 2021
Safety and tolerability evaluation of erenumab for the preventive treatment of migraineChristina I Deligianni, Dimos D Mitsikostas, Messoud Ashina
The Journal of Headache and Pain|March 31, 2017
Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcomeDimos D Mitsikostas, Srdjan Ljubisavljevic, Christina I Deligianni
Current Opinion in Neurology|May 2, 2012
Depression in headaches: chronificationChristina I Deligianni, Michail Vikelis, Dimos D Mitsikostas
The Journal of Headache and Pain|September 3, 2015
Neck pain in episodic migraine: premonitory symptom or part of the attack?Christian Lampl, Mirjam Rudolph, Christina I Deligianni, et al.
Cephalalgia : an International Journal of Headache|February 11, 2021
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysisKonstantina Drellia, Lili Kokoti, Christina I Deligianni, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far?Theodoros Mavridis, Christina I Deligianni, Georgios Karagiorgis, et al.
Pain Management|May 30, 2025
Repurposed versus disease-specific medicinals for the prophylaxis of migraine: an updated systematic reviewSavvas-Ilias Christofilos, Theodoros Mavridis, Viktor Gkotzamanis, et al.
Cephalalgia : an International Journal of Headache|August 10, 2022
Visual snow: A systematic review and a case seriesStefanos N Sampatakakis, Loukas Lymperopoulos, Theodoros Mavridis, et al.
Pageof 3